Healthcare resource utilization and associated costs in patients with metastatic castration-resistant prostate cancer in Greece
{{output}}
Background: Prostate cancer is a leading cause of cancer death among men. Metastatic castration-resistant prostate cancer (mCRPC) treatment has changed dramatically since the introduction of novel hormonal agents (NHAs); however,... ...
